APO Research
Talk to an analyst

APO RESEARCH · REPORT

1-Iodobutane

1-Iodobutane is a halogen-containing chemical substance identified by its named positional structure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Iodobutane. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which supplied interfaces and acceptance criteria define 1-Iodobutane?

The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Iodobutane. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.

Selected research

Market Outlook & Growth Opportunities

Global 1-Iodobutane Market Outlook and Growth Opportunities 2026

23 December 2025193 pages

Choose your research edition.

Industry Research1-Iodobutane Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal 1-Iodobutane Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal 1-Iodobutane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 1-Iodobutane Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal 1-Iodobutane Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global 1-Iodobutane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 1-Iodobutane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 1-Iodobutane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 1-Iodobutane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 1-Iodobutane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 1-Iodobutane market include Amitychem, Dynarx, Dayang Chem (Hangzhou), Dideu, Gihi Chemicals, Yongjin Group, Xinhu Chemical, Senfeida and Nippoh Chemicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 1-Iodobutane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 1-Iodobutane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 1-Iodobutane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 1-Iodobutane market size, projected growth trends, production technologies, key applications, and end-use industries.

1-Iodobutane Segment by Company

Amitychem

Dynarx

Dayang Chem (Hangzhou)

Dideu

Gihi Chemicals

Yongjin Group

Xinhu Chemical

Senfeida

Nippoh Chemicals

1-Iodobutane Segment by Type

Purity Below 98%

Purity Above 98%

1-Iodobutane Segment by Application

Electronics

Chemical

Pharmaceutical

Others

1-Iodobutane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 1-Iodobutane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 1-Iodobutane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 1-Iodobutane significant trends, drivers, influence factors in global and regions.

6. To analyze 1-Iodobutane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1-Iodobutane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 1-Iodobutane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1-Iodobutane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 1-Iodobutane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 1-Iodobutane industry.

Chapter 3: Detailed analysis of 1-Iodobutane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 1-Iodobutane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 1-Iodobutane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 1-Iodobutane Industry Trends Table 2. 1-Iodobutane Industry Drivers Table 3. 1-Iodobutane Industry Opportunities and Challenges Table 4. 1-Iodobutane Industry Restraints Table 5. Global 1-Iodobutane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 1-Iodobutane Revenue Share by Company (2021-2026) Table 7. Global 1-Iodobutane Sales Volume by Company (Tons) & (2021-2026) Table 8. Global 1-Iodobutane Sales Volume Share by Company (2021-2026) Table 9. Global 1-Iodobutane Average Price (US$/Ton) of Company (2021-2026) Table 10. Global 1-Iodobutane Company Ranking, (2024-2026) & (USD Million) Table 11. Global 1-Iodobutane Key Company Manufacturing Base & Headquarters Table 12. Global 1-Iodobutane Company, Product Type & Application Table 13. Global 1-Iodobutane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 1-Iodobutane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity Below 98% Table 18. Significant Companies of Purity Above 98% Table 19. Global 1-Iodobutane Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global 1-Iodobutane Sales Volume by Type (2021-2026) & (Tons) Table 21. Global 1-Iodobutane Sales Volume by Type (2027-2032) & (Tons) Table 22. Global 1-Iodobutane Sales Volume Share by Type (2021-2026) Table 23. Global 1-Iodobutane Sales Volume Share by Type (2027-2032) Table 24. Global 1-Iodobutane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global 1-Iodobutane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global 1-Iodobutane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global 1-Iodobutane Sales Value Share by Type (2021-2026) Table 28. Global 1-Iodobutane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Electronics Table 30. Significant Companies of Chemical Table 31. Significant Companies of Pharmaceutical Table 32. Significant Companies of Others Table 33. Global 1-Iodobutane Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global 1-Iodobutane Sales Volume by Application (2021-2026) & (Tons) Table 35. Global 1-Iodobutane Sales Volume by Application (2027-2032) & (Tons) Table 36. Global 1-Iodobutane Sales Volume Share by Application (2021-2026) Table 37. Global 1-Iodobutane Sales Volume Share by Application (2027-2032) Table 38. Global 1-Iodobutane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global 1-Iodobutane Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global 1-Iodobutane Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global 1-Iodobutane Sales Value Share by Application (2021-2026) Table 42. Global 1-Iodobutane Sales Value Share by Application (2027-2032) Table 43. Global 1-Iodobutane Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global 1-Iodobutane Sales by Region (2021-2026) & (Tons) Table 45. Global 1-Iodobutane Sales Market Share by Region (2021-2026) Table 46. Global 1-Iodobutane Sales by Region (2027-2032) & (Tons) Table 47. Global 1-Iodobutane Sales Market Share by Region (2027-2032) Table 48. Global 1-Iodobutane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global 1-Iodobutane Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global 1-Iodobutane Sales Value Share by Region (2021-2026) Table 51. Global 1-Iodobutane Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global 1-Iodobutane Sales Value Share by Region (2027-2032) Table 53. Global 1-Iodobutane Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global 1-Iodobutane Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global 1-Iodobutane Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global 1-Iodobutane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global 1-Iodobutane Sales by Country (2021-2026) & (Tons) Table 58. Global 1-Iodobutane Sales Market Share by Country (2021-2026) Table 59. Global 1-Iodobutane Sales by Country (2027-2032) & (Tons) Table 60. Global 1-Iodobutane Sales Market Share by Country (2027-2032) Table 61. Global 1-Iodobutane Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global 1-Iodobutane Sales Value Market Share by Country (2021-2026) Table 63. Global 1-Iodobutane Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global 1-Iodobutane Sales Value Market Share by Country (2027-2032) Table 65. Amitychem Company Information Table 66. Amitychem Business Overview Table 67. Amitychem 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Amitychem 1-Iodobutane Product Portfolio Table 69. Amitychem Recent Development Table 70. Dynarx Company Information Table 71. Dynarx Business Overview Table 72. Dynarx 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Dynarx 1-Iodobutane Product Portfolio Table 74. Dynarx Recent Development Table 75. Dayang Chem (Hangzhou) Company Information Table 76. Dayang Chem (Hangzhou) Business Overview Table 77. Dayang Chem (Hangzhou) 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Dayang Chem (Hangzhou) 1-Iodobutane Product Portfolio Table 79. Dayang Chem (Hangzhou) Recent Development Table 80. Dideu Company Information Table 81. Dideu Business Overview Table 82. Dideu 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Dideu 1-Iodobutane Product Portfolio Table 84. Dideu Recent Development Table 85. Gihi Chemicals Company Information Table 86. Gihi Chemicals Business Overview Table 87. Gihi Chemicals 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Gihi Chemicals 1-Iodobutane Product Portfolio Table 89. Gihi Chemicals Recent Development Table 90. Yongjin Group Company Information Table 91. Yongjin Group Business Overview Table 92. Yongjin Group 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Yongjin Group 1-Iodobutane Product Portfolio Table 94. Yongjin Group Recent Development Table 95. Xinhu Chemical Company Information Table 96. Xinhu Chemical Business Overview Table 97. Xinhu Chemical 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Xinhu Chemical 1-Iodobutane Product Portfolio Table 99. Xinhu Chemical Recent Development Table 100. Senfeida Company Information Table 101. Senfeida Business Overview Table 102. Senfeida 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Senfeida 1-Iodobutane Product Portfolio Table 104. Senfeida Recent Development Table 105. Nippoh Chemicals Company Information Table 106. Nippoh Chemicals Business Overview Table 107. Nippoh Chemicals 1-Iodobutane Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Nippoh Chemicals 1-Iodobutane Product Portfolio Table 109. Nippoh Chemicals Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. 1-Iodobutane Distributors List Table 113. 1-Iodobutane Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. 1-Iodobutane Product Image Figure 2. Global 1-Iodobutane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 4. Global 1-Iodobutane Sales (2021-2032) & (Tons) Figure 5. Global 1-Iodobutane Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global 1-Iodobutane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity Below 98% Image Figure 10. Purity Above 98% Image Figure 11. Global 1-Iodobutane Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global 1-Iodobutane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global 1-Iodobutane Sales Volume Share by Type (2021-2032) Figure 14. Global 1-Iodobutane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global 1-Iodobutane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global 1-Iodobutane Sales Value Share by Type (2021-2032) Figure 17. Electronics Image Figure 18. Chemical Image Figure 19. Pharmaceutical Image Figure 20. Others Image Figure 21. Global 1-Iodobutane Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global 1-Iodobutane Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global 1-Iodobutane Sales Volume Share by Application (2021-2032) Figure 24. Global 1-Iodobutane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global 1-Iodobutane Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global 1-Iodobutane Sales Value Share by Application (2021-2032) Figure 27. Global 1-Iodobutane Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global 1-Iodobutane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global 1-Iodobutane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global 1-Iodobutane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 32. North America 1-Iodobutane Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 34. Europe 1-Iodobutane Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific 1-Iodobutane Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 38. South America 1-Iodobutane Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa 1-Iodobutane Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa 1-Iodobutane Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt 1-Iodobutane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt 1-Iodobutane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt 1-Iodobutane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. 1-Iodobutane Value Chain Figure 126. Manufacturing Cost Structure Figure 127. 1-Iodobutane Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Below 98%
  • Purity Above 98%
Applications
  • Electronics
  • Chemical
  • Pharmaceutical
  • Others
Companies covered
  • Amitychem
  • Dynarx
  • Dayang Chem (Hangzhou)
  • Dideu
  • Gihi Chemicals
  • Yongjin Group
  • Xinhu Chemical
  • Senfeida
  • Nippoh Chemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 1-Iodobutane Sales Value (2021-2032)
  4. 1.2.2 Global 1-Iodobutane Sales Volume (2021-2032)
  5. 1.2.3 Global 1-Iodobutane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 1-Iodobutane Market Dynamics
  1. 2.1 1-Iodobutane Industry Trends
  2. 2.2 1-Iodobutane Industry Drivers
  3. 2.3 1-Iodobutane Industry Opportunities and Challenges
  4. 2.4 1-Iodobutane Industry Restraints
3 1-Iodobutane Market by Company
  1. 3.1 Global 1-Iodobutane Company Revenue Ranking in 2025
  2. 3.2 Global 1-Iodobutane Revenue by Company (2021-2026)
  3. 3.3 Global 1-Iodobutane Sales Volume by Company (2021-2026)
  4. 3.4 Global 1-Iodobutane Average Price by Company (2021-2026)
  5. 3.5 Global 1-Iodobutane Company Ranking (2024-2026)
  6. 3.6 Global 1-Iodobutane Company Manufacturing Base and Headquarters
  7. 3.7 Global 1-Iodobutane Company Product Type and Application
  8. 3.8 Global 1-Iodobutane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 1-Iodobutane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 1-Iodobutane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 1-Iodobutane Market by Type
  1. 4.1 1-Iodobutane Type Introduction
  2. 4.1.1 Purity Below 98%
  3. 4.1.2 Purity Above 98%
  4. 4.2 Global 1-Iodobutane Sales Volume by Type
  5. 4.2.1 Global 1-Iodobutane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global 1-Iodobutane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global 1-Iodobutane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global 1-Iodobutane Sales Value by Type
  9. 4.3.1 Global 1-Iodobutane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global 1-Iodobutane Sales Value by Type (2021-2032)
  11. 4.3.3 Global 1-Iodobutane Sales Value Share by Type (2021-2032)
5 1-Iodobutane Market by Application
  1. 5.1 1-Iodobutane Application Introduction
  2. 5.1.1 Electronics
  3. 5.1.2 Chemical
  4. 5.1.3 Pharmaceutical
  5. 5.1.4 Others
  6. 5.2 Global 1-Iodobutane Sales Volume by Application
  7. 5.2.1 Global 1-Iodobutane Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global 1-Iodobutane Sales Volume by Application (2021-2032)
  9. 5.2.3 Global 1-Iodobutane Sales Volume Share by Application (2021-2032)
  10. 5.3 Global 1-Iodobutane Sales Value by Application
  11. 5.3.1 Global 1-Iodobutane Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global 1-Iodobutane Sales Value by Application (2021-2032)
  13. 5.3.3 Global 1-Iodobutane Sales Value Share by Application (2021-2032)
6 1-Iodobutane Regional Sales and Value Analysis
  1. 6.1 Global 1-Iodobutane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 1-Iodobutane Sales by Region (2021-2032)
  3. 6.2.1 Global 1-Iodobutane Sales by Region: 2021-2026
  4. 6.2.2 Global 1-Iodobutane Sales by Region (2027-2032)
  5. 6.3 Global 1-Iodobutane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 1-Iodobutane Sales Value by Region (2021-2032)
  7. 6.4.1 Global 1-Iodobutane Sales Value by Region: 2021-2026
  8. 6.4.2 Global 1-Iodobutane Sales Value by Region (2027-2032)
  9. 6.5 Global 1-Iodobutane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 1-Iodobutane Sales Value (2021-2032)
  12. 6.6.2 North America 1-Iodobutane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 1-Iodobutane Sales Value (2021-2032)
  15. 6.7.2 Europe 1-Iodobutane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 1-Iodobutane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 1-Iodobutane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 1-Iodobutane Sales Value (2021-2032)
  21. 6.9.2 South America 1-Iodobutane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 1-Iodobutane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 1-Iodobutane Sales Value Share by Country, 2025 VS 2032
7 1-Iodobutane Country-level Sales and Value Analysis
  1. 7.1 Global 1-Iodobutane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 1-Iodobutane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 1-Iodobutane Sales by Country (2021-2032)
  4. 7.3.1 Global 1-Iodobutane Sales by Country (2021-2026)
  5. 7.3.2 Global 1-Iodobutane Sales by Country (2027-2032)
  6. 7.4 Global 1-Iodobutane Sales Value by Country (2021-2032)
  7. 7.4.1 Global 1-Iodobutane Sales Value by Country (2021-2026)
  8. 7.4.2 Global 1-Iodobutane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 1-Iodobutane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 1-Iodobutane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 1-Iodobutane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 1-Iodobutane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 1-Iodobutane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 1-Iodobutane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 1-Iodobutane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 1-Iodobutane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 1-Iodobutane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 1-Iodobutane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 1-Iodobutane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 1-Iodobutane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 1-Iodobutane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 1-Iodobutane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 1-Iodobutane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 1-Iodobutane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 1-Iodobutane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 1-Iodobutane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 1-Iodobutane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 1-Iodobutane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 1-Iodobutane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 1-Iodobutane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 1-Iodobutane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 1-Iodobutane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 1-Iodobutane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 1-Iodobutane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 1-Iodobutane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 1-Iodobutane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 1-Iodobutane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 1-Iodobutane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amitychem
  2. 8.1.1 Amitychem Company Information
  3. 8.1.2 Amitychem Business Overview
  4. 8.1.3 Amitychem 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amitychem 1-Iodobutane Product Portfolio
  6. 8.1.5 Amitychem Recent Developments
  7. 8.2 Dynarx
  8. 8.2.1 Dynarx Company Information
  9. 8.2.2 Dynarx Business Overview
  10. 8.2.3 Dynarx 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dynarx 1-Iodobutane Product Portfolio
  12. 8.2.5 Dynarx Recent Developments
  13. 8.3 Dayang Chem (Hangzhou)
  14. 8.3.1 Dayang Chem (Hangzhou) Company Information
  15. 8.3.2 Dayang Chem (Hangzhou) Business Overview
  16. 8.3.3 Dayang Chem (Hangzhou) 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dayang Chem (Hangzhou) 1-Iodobutane Product Portfolio
  18. 8.3.5 Dayang Chem (Hangzhou) Recent Developments
  19. 8.4 Dideu
  20. 8.4.1 Dideu Company Information
  21. 8.4.2 Dideu Business Overview
  22. 8.4.3 Dideu 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dideu 1-Iodobutane Product Portfolio
  24. 8.4.5 Dideu Recent Developments
  25. 8.5 Gihi Chemicals
  26. 8.5.1 Gihi Chemicals Company Information
  27. 8.5.2 Gihi Chemicals Business Overview
  28. 8.5.3 Gihi Chemicals 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gihi Chemicals 1-Iodobutane Product Portfolio
  30. 8.5.5 Gihi Chemicals Recent Developments
  31. 8.6 Yongjin Group
  32. 8.6.1 Yongjin Group Company Information
  33. 8.6.2 Yongjin Group Business Overview
  34. 8.6.3 Yongjin Group 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Yongjin Group 1-Iodobutane Product Portfolio
  36. 8.6.5 Yongjin Group Recent Developments
  37. 8.7 Xinhu Chemical
  38. 8.7.1 Xinhu Chemical Company Information
  39. 8.7.2 Xinhu Chemical Business Overview
  40. 8.7.3 Xinhu Chemical 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xinhu Chemical 1-Iodobutane Product Portfolio
  42. 8.7.5 Xinhu Chemical Recent Developments
  43. 8.8 Senfeida
  44. 8.8.1 Senfeida Company Information
  45. 8.8.2 Senfeida Business Overview
  46. 8.8.3 Senfeida 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Senfeida 1-Iodobutane Product Portfolio
  48. 8.8.5 Senfeida Recent Developments
  49. 8.9 Nippoh Chemicals
  50. 8.9.1 Nippoh Chemicals Company Information
  51. 8.9.2 Nippoh Chemicals Business Overview
  52. 8.9.3 Nippoh Chemicals 1-Iodobutane Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nippoh Chemicals 1-Iodobutane Product Portfolio
  54. 8.9.5 Nippoh Chemicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 1-Iodobutane Value Chain Analysis
  2. 9.1.1 1-Iodobutane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 1-Iodobutane Sales Mode & Process
  6. 9.2 1-Iodobutane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 1-Iodobutane Distributors
  9. 9.2.3 1-Iodobutane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst